177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma

Robert Hawkins; Yizhou Jiang; Paul C Lorigan; Fiona C Thistlethwaite; Manon Pillai; Martine Thomas; Natalia Kirillova; John S Bridgeman; Gray Kueberuwa; Ryan D Guest; Zachary J Roberts

doi:10.1136/jitc-2021-SITC2021.177

Article info

Regular and Young Investigator Award Abstracts

Cellular Therapies

177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma

Free

Authors

Robert Hawkins Instil Bio, Inc., Dallas, TX, USA and The Christie, NHS Foundation Trust and University of Manchester, Manchester, TX, UK PubMed articles Google scholar articles
Yizhou Jiang Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
Paul C Lorigan The Christie, NHS Foundation Trust, Manchester, UK PubMed articles Google scholar articles
Fiona C Thistlethwaite The Christie, NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK PubMed articles Google scholar articles
Manon Pillai The Christie, NHS Foundation Trust, Manchester, UK PubMed articles Google scholar articles
Martine Thomas Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
Natalia Kirillova Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
John S Bridgeman Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
Gray Kueberuwa Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
Ryan D Guest Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles
Zachary J Roberts Instil Bio, Inc., Dallas, TX, USA PubMed articles Google scholar articles

Citation

Hawkins R, Jiang Y, Lorigan PC, et al

177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.177

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password